Literature DB >> 1541680

A common type of the spectrin alpha I 46-50a-kD peptide abnormality in hereditary elliptocytosis and pyropoikilocytosis is associated with a mutation distant from the proteolytic cleavage site. Evidence for the functional importance of the triple helical model of spectrin.

P G Gallagher1, W T Tse, T Coetzer, M C Lecomte, M Garbarz, H S Zarkowsky, A Baruchel, S K Ballas, D Dhermy, J Palek.   

Abstract

We studied nine individuals from five unrelated families with alpha I/46-50a hereditary elliptocytosis (HE) or hereditary pyropoikilocytosis (HPP), including one of the original HHP probands first reported by Zarkowsky and colleagues (1975. Br. J. Haematol. 29:537-543). Biochemical analysis of erythrocyte membrane proteins from these patients revealed, as a common abnormality, the presence of the alpha I/46-50a peptide after limited tryptic digestion of spectrin. The polymerase chain reaction was utilized to study the structure of the DNA encoding the alpha I domain of spectrin in the affected individuals. The DNA sequence of the alpha-spectrin gene encoding the region of the alpha-spectrin chain surrounding the abnormal proteolytic cleavage site was normal. We identified a point mutation causing the replacement of a highly conserved leucine residue by proline at position 207 in the alpha-spectrin chain, a site 51 residues to the amino-terminal side of the abnormal proteolytic cleavage site. Analysis of the proposed triple helical model of spectrin repeats reveals that the mutation occurs in helix 2 at a position directly opposite the abnormal proteolytic cleavage site in helix 3, making this the first report of a mutation occurring in helix 2 of a repeat in the alpha I domain of spectrin. These results add to the molecular heterogeneity of mutations associated with HE/HPP and provide further support for the proposed triple helical model of spectrin. Disruption of this proposed alpha-helical structure by helix-breaking proline substitutions may result in a functionally defective spectrin chain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541680      PMCID: PMC442935          DOI: 10.1172/JCI115669

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

Review 1.  Hereditary elliptocytosis, spherocytosis and related disorders: consequences of a deficiency or a mutation of membrane skeletal proteins.

Authors:  J Palek
Journal:  Blood Rev       Date:  1987-09       Impact factor: 8.250

2.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

3.  Oligomeric states of spectrin in normal erythrocyte membranes: biochemical and electron microscopic studies.

Authors:  S C Liu; P Windisch; S Kim; J Palek
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

4.  A technique to detect reduced mechanical stability of red cell membranes: relevance to elliptocytic disorders.

Authors:  N Mohandas; M R Clark; B P Health; M Rossi; L C Wolfe; S E Lux; S B Shohet
Journal:  Blood       Date:  1982-04       Impact factor: 22.113

5.  Spectrin beta-chain variant associated with hereditary elliptocytosis.

Authors:  D Dhermy; M C Lecomte; M Garbarz; O Bournier; C Galand; H Gautero; C Feo; N Alloisio; J Delaunay; P Boivin
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

6.  Erythrocyte spectrin is comprised of many homologous triple helical segments.

Authors:  D W Speicher; V T Marchesi
Journal:  Nature       Date:  1984 Sep 13-19       Impact factor: 49.962

7.  Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes.

Authors:  P Matsudaira
Journal:  J Biol Chem       Date:  1987-07-25       Impact factor: 5.157

8.  Abnormal spectrin in hereditary elliptocytosis.

Authors:  S L Marchesi; W J Knowles; J S Morrow; M Bologna; V T Marchesi
Journal:  Blood       Date:  1986-01       Impact factor: 22.113

9.  Molecular and functional changes in spectrin from patients with hereditary pyropoikilocytosis.

Authors:  W J Knowles; J S Morrow; D W Speicher; H S Zarkowsky; N Mohandas; W C Mentzer; S B Shohet; V T Marchesi
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

10.  Double inheritance of an alpha I/65 spectrin variant in a child with homozygous elliptocytosis.

Authors:  M Garbarz; M C Lecomte; D Dhermy; C Feo; I Chaveroche; H Gautero; O Bournier; C Picat; A Goepp; P Boivin
Journal:  Blood       Date:  1986-06       Impact factor: 22.113

View more
  12 in total

1.  Genomic anatomy of a premier major histocompatibility complex paralogous region on chromosome 1q21-q22.

Authors:  T Shiina; A Ando; Y Suto; F Kasai; A Shigenari; N Takishima; E Kikkawa; K Iwata; Y Kuwano; Y Kitamura; Y Matsuzawa; K Sano; M Nogami; H Kawata; S Li; Y Fukuzumi; M Yamazaki; H Tashiro; G Tamiya; A Kohda; K Okumura; T Ikemura; E Soeda; N Mizuki; M Kimura; S Bahram; H Inoko
Journal:  Genome Res       Date:  2001-05       Impact factor: 9.043

2.  A novel splicing mutation of the alpha-spectrin gene in the original hereditary pyropoikilocytosis kindred.

Authors:  Daniel B Costa; Larisa Lozovatsky; Patrick G Gallagher; Bernard G Forget
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

Review 3.  Probing structures of large protein complexes using zero-length cross-linking.

Authors:  Roland F Rivera-Santiago; Sira Sriswasdi; Sandra L Harper; David W Speicher
Journal:  Methods       Date:  2015-05-01       Impact factor: 3.608

4.  Probing large conformational rearrangements in wild-type and mutant spectrin using structural mass spectrometry.

Authors:  Sira Sriswasdi; Sandra L Harper; Hsin-Yao Tang; Patrick G Gallagher; David W Speicher
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-22       Impact factor: 11.205

5.  Aberrant splicing contributes to severe α-spectrin-linked congenital hemolytic anemia.

Authors:  Patrick G Gallagher; Yelena Maksimova; Kimberly Lezon-Geyda; Peter E Newburger; Desiree Medeiros; Robin D Hanson; Jennifer Rothman; Sara Israels; Donna A Wall; Robert F Sidonio; Colin Sieff; L Kate Gowans; Nupur Mittal; Roland Rivera-Santiago; David W Speicher; Susan J Baserga; Vincent P Schulz
Journal:  J Clin Invest       Date:  2019-04-30       Impact factor: 14.808

6.  An alpha-spectrin mutation responsible for hereditary elliptocytosis associated in cis with the alpha v/41 polymorphism.

Authors:  N Dalla Venezia; R Wilmotte; L Morlé; A Forissier; N Parquet; M Garbarz; T Rousset; D Dhermy; N Alloisio; J Delaunay
Journal:  Hum Genet       Date:  1993-02       Impact factor: 4.132

7.  Low expression allele alpha LELY of red cell spectrin is associated with mutations in exon 40 (alpha V/41 polymorphism) and intron 45 and with partial skipping of exon 46.

Authors:  R Wilmotte; J Maréchal; L Morlé; F Baklouti; N Philippe; R Kastally; L Kotula; J Delaunay; N Alloisio
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Molecular basis and haplotyping of the alphaII domain polymorphisms of spectrin: application to the study of hereditary elliptocytosis and pyropoikilocytosis.

Authors:  P G Gallagher; L Kotula; Y Wang; S L Marchesi; P J Curtis; D W Speicher; B G Forget
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

9.  Mutation of a highly conserved residue of betaI spectrin associated with fatal and near-fatal neonatal hemolytic anemia.

Authors:  P G Gallagher; M J Petruzzi; S A Weed; Z Zhang; S L Marchesi; N Mohandas; J S Morrow; B G Forget
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

10.  Beta-III spectrin mutation L253P associated with spinocerebellar ataxia type 5 interferes with binding to Arp1 and protein trafficking from the Golgi.

Authors:  Yvonne L Clarkson; Trudi Gillespie; Emma M Perkins; Alastair R Lyndon; Mandy Jackson
Journal:  Hum Mol Genet       Date:  2010-07-05       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.